KG#203
(Plasmid
#110880)
-
PurposeExpresses the C. elegans pde-4 (isoform d) cDNA pan-neuronally
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 110880 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepUC
- Backbone size w/o insert (bp) 2617
- Total vector size (bp) 6936
-
Vector typeBacterial Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert 1
-
Gene/Insert namerab-3 promoter
-
SpeciesC. elegans (nematode)
-
Insert Size (bp)1208
Cloning Information for Gene/Insert 1
- Cloning method Unknown
- 5′ sequencing primer Unknown (Common Sequencing Primers)
Gene/Insert 2
-
Gene/Insert namepde-4d (isoform d) cDNA
-
SpeciesC. elegans (nematode)
-
Insert Size (bp)2025
Cloning Information for Gene/Insert 2
- Cloning method Unknown
- 5′ sequencing primer Unknown (Common Sequencing Primers)
Gene/Insert 3
-
Gene/Insert nameunc-54 3' control region with 1 artificial intron just upstream and 1 artificial intron in control region
-
SpeciesC. elegans (nematode)
-
Insert Size (bp)993
Cloning Information for Gene/Insert 3
- Cloning method Unknown
- 5′ sequencing primer Unknown (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
-
Article Citing this Plasmid
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
Used StrataScript Reverse Transcriptase and a primer engineered with a restriction site to make the full length pde-4d cDNA (2025 bp). We then nicked the duplexed RNA with RNAse H and synthesize the 2nd strand of cDNA using E. coli DNA Polymerase I, which can do nick translation. The DNA Pol I uses the nicked RNA as primers to synthesize the second strand (it chews up the RNA in front of it and replaces with DNA). We then used Accuprime Pfx and primers engineered with restriction sites to amplify and clone the cDNA into Nhe I/ Age I cut KG#59 (rab-3:: expression vector; 4.9 Kb). Transformed into XL1-Blue electrocompetent cells. Qiagen miniprepped 2 clones to found those with correct insert, then submitted the 2 clones for sequence. Choose one clone that had correct sequence and made glycerol stock.
Features of the expression construct: This expression construct has a promoter (rab-3) that will drive expression of the cDNA throughout the nervous system. This construct includes only the coding region of pde-4d, and the sequence is taken from the Wormbase WS134 release, gene designation R153.1d. This 'd' isoform seems to be the most common splice variant. The sequence AAAA is engineered just after the 5' restriction site and just before the initiator ATG. An AT immediately follows the TAA stop codon for a consensus stop site. Three introns (all located in untranslated regions of the vector) are present to give stable and uniform expression (1 in the 5' UTR, 1 just upstream of the unc-54 3' end, and 1 in the unc-54 3' end sequence). The vector includes the unc-54 3' untranslated end containing a poly A addition signal to stop transcription and provide a 3' UTR for the transcript. The vector also contains a "decoy" (see 1995 vector kit documentation) upstream of the promoter to reduce background expression in the gut and pharynx from read-through transcription.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
KG#203 was a gift from Kenneth Miller (Addgene plasmid # 110880 ; http://n2t.net/addgene:110880 ; RRID:Addgene_110880) -
For your References section:
The Dunce cAMP phosphodiesterase PDE-4 negatively regulates G alpha(s)-dependent and G alpha(s)-independent cAMP pools in the Caenorhabditis elegans synaptic signaling network. Charlie NK, Thomure AM, Schade MA, Miller KG. Genetics. 2006 May;173(1):111-30. doi: 10.1534/genetics.105.054007. Epub 2006 Apr 19. 10.1534/genetics.105.054007 PubMed 16624912